Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3E5A59
Fri, 19.12.2025
SYNBIOTIC SE
Company Name:
SYNBIOTIC SE
ISIN:
DE000A3E5A59
Reason for the research:
Update
Recommendation:
BUY
from:
19.12.2025
Target price:
EUR 5.50
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Additional capital to support strategic realignment; chg. PT
Recent developments at SYNBIOTIC have sharpe [ … ]
Tue, 16.12.2025
SYNBIOTIC SE
Strategic Investment: CANSOUL acquires stake in SYNBIOTIC
Düsseldorf, 16 December 2025 – The European medical cannabis and industrial hemp group SYNBIOTIC SE (ISIN: DE000A3E5A59 | WKN: A3E5A5) announces a strategic equity investment. The specialised cannabis and hemp equity fund CANSOUL – Hanf Aktien Global (WKN: A2PX8U | ISIN: LI0514446843) has ac [ … ]
Tue, 18.11.2025
SYNBIOTIC SE
SYNBIOTIC strengthens its presence at international events and monitors advances in cannabis research
The European medical cannabis and industrial hemp group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) is entering the final stretch of the year with strategic initiatives: The Group has already participated in the international Talman House Roadsho [ … ]
Tue, 21.10.2025
SYNBIOTIC SE
SYNBIOTIC welcomes Green Party’s proposal for the Industrial Hemp Liberalization Act and calls for objectivity in the medical cannabis debate
The European medical cannabis and industrial hemp group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) considers the bill introduced by Bündnis 90/Die Grünen on 7 October 2025 to amend the Consumer Cannabis Ac [ … ]
Mon, 20.10.2025
SYNBIOTIC SE
Company Name:
SYNBIOTIC SE
ISIN:
DE000A3E5A59
Reason for the research:
Update
Recommendation:
BUY
from:
20.10.2025
Target price:
EUR 6.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
As a consequence, SYNBIOTIC reduced its FY25 guidance to € 17m in sales (old: € 30m, eNuW old: [ … ]
Thu, 02.10.2025
SYNBIOTIC SE
Positive Outlook: Cannabis Legalization Review and Trump’s Endorsement Send Encouraging Signals
The European corporate group for medical cannabis and industrial hemp, SYNBIOTIC SE (ISIN DE000A3E5A59 / WKN A3E5A5), enters the fourth quarter of 2025 with renewed optimism.
"It’s been a good week for the cannabis and hemp industry. The interim report o [ … ]
Thu, 14.08.2025
SYNBIOTIC SE
Across the pond: SYNBIOTIC attracts international investors with established intercontinental networks
SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5), the European holding for medical cannabis and industrial hemp, is strengthening its international capital access by partnering with North American fund raising specialists and well-known multipliers. [ … ]
Tue, 29.07.2025
SYNBIOTIC SE
Revenue expected to triple by 2027: Focus on growth markets for medical cannabis and industrial hemp underscores positive outlook for SYNBIOTIC
The European company group for medical cannabis and industrial hemp SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) will focus its strategic expansion even more on the fastest-growing markets for medical cann [ … ]
Wed, 11.06.2025
SYNBIOTIC SE
Successful roadshow continues: SYNBIOTIC keeps expanding its presence in the cannabis and hemp industry
The European medical cannabis and industrial hemp group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) is increasingly benefiting from its strong visibility and attention in the cannabis industry - and investors and shareholders are also benefitin [ … ]
Thu, 17.04.2025
SYNBIOTIC SE
IRIS Capital invests in SYNBIOTIC's growth strategy
The European medical cannabis and industrial hemp group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) and the venture capital company IRIS Capital Investment have entered into a strategic partnership. The French investment company will actively support SYNBIOTIC's growth strategy. In a first phase [ … ]
